Feasibility study investigating the efficacy and safety of hybeid endoscopic submucosal dissection
Ontology highlight
ABSTRACT: Interventions: Patients with 20-30mm colorectal adenoma/intramucosal cancer were considered eligible. Hybrid ESD was performed using newly-developed device which enable scircumferential incision and submucosal dissection.
Primary outcome(s): Complication rate assessed after endoscopic treatment
Study Design: Single arm Non-randomized
DISEASE(S): Colorectal Adenoma/intramucosal Cancer
PROVIDER: 2637804 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA